KSV01

· TCRx Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KSV01, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 1]